May 25 (Reuters) - Vita Life Sciences Ltd VLS.AX :
* SEES SALES GROWTH OF 8-10% ON PREVIOUS YEAR TO AROUND $19M FOR H1
* SEES H1 EBIT GROWTH OF AROUND 15% ON PREVIOUS HALF YEAR
* SEES FY EBIT TO BE SLIGHTLY LOWER COMPARED TO FY 2017 DUE TO INCREASE INVESTMENT IN BRAND EQUITY INCLUDING ADVERTISING & PROMOTION